Navigation Links
As Pradaxa Lawsuits Move Forward, Bernstein Liebhard LLP Notes Manufacturer is Working on Possible Antidote for Internal Bleeding Caused by the Blood-Thinner
Date:12/4/2013

New York, New York (PRWEB) December 04, 2013

As nearly 2,000 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) alleging injuries due to internal bleeding continue to move forward in federal court, Bernstein Liebhard LLP notes that Boehringer Ingelheim Pharmaceuticals, the manufacturer of the blood-thinner, has announced results from a clinical trial of a possible antidote to reverse dangerous internal bleeding that can sometimes accompany use of the drug. According to a recent Reuters report, the early stage trial involving 150 healthy volunteers indicated that the antidote worked “immediately and completely.” However, larger trials will be needed to prove the antidote’s safety and effectiveness.*

“This is an interesting development, as a lack of an effective antidote for internal bleeding is a key factor in hundreds of Pradaxa lawsuits currently pending against Boehringer Ingelheim. Unfortunately, the availability of any such antidote will have come too late for the alleged victims of Pradaxa,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding side effects.

Pradaxa Lawsuits
According to court documents, just over 1,900 Pradaxa lawsuits are currently pending in the federal multidistrict litigation underway in U.S. District Court, Southern District of Illinois. All of the claims were filed on behalf of alleged victims of Pradaxa bleeding side effects. Among other things, the lawsuits allege that Boehringer Ingelheim failed to provide adequate warnings regarding the lack of an antidote for internal bleeding caused by the medication. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

According to Bernstein Liebhard, announcement of the possible antidote came a little over a month after a study conducted by the Institute for Safe Medicine Practices (ISMP) revealed that Pradaxa had been named in more adverse event reports than any other drug monitored by the U.S. Food & Drug Administration (FDA). According to the report, the FDA logged more than 3,200 Pradaxa side effect reports in 2012, including 582 that had fatal outcomes. The same year, warfarin, a much older blood thinner, was the subject of just 861 reports, including 56 deaths.**

Individuals who allegedly suffered serious Pradaxa bleeding side effects may be entitled to compensation for their injury-related damages. To learn more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website. For a free case review, please call 800-511-5092.

*reuters.com/article/2013/11/18/pradaxa-antidote-idUSL2N0J300920131118, Reuters November 19, 2013
**ismp.org/QuarterWatch/pdfs/2012Q4.pdf, ISMP, October 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb11392987.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit News: Wright & Schulte LLC Reports on Growing Pradaxa Bleeding Litigation, As Number of Filings Exceed 1,800
2. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on November Status Conference in Federal Pradaxa Bleeding Litigation
3. Pradaxa Bleeding Allegations Lawyer: Resource4thePeople Reports New Study May Produce Treatment to Reverse Anti-Clotting Medication Effects
4. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
5. Pradaxa Lawsuits Progress, as Bernstein Liebhard LLP Notes Establishment of Bellwether Case Selection Protocol in Federal Pradaxa Bleeding Litigation
6. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal Pradaxa Bleeding Litigation
7. New Data on Pradaxa Bleeding Side Effects Draws Comment from Pradaxa Lawsuit Lawyers at Wright & Schulte LLC
8. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
9. DrugNews: Court Records Show Growth In Claims Alleging Pradaxa Bleeding Injury
10. Doyle Raizner Attorney Presenting Pradaxa MDL Update at AAJ Seminar
11. DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... IL (PRWEB) , ... February 24, 2017 , ... The ... the 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. ... Choice will be showcased and the winner revealed at the 31st annual iaedp Symposium, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head Over ... on February 12th. Ms. Esparza qualified into this prestigious status after winning ... in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in the ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will ... the 2016 National Education Policy Center Bunkum Award. We invite you to enjoy our ... This year’s Bunkum winner is the Center for American Progress (CAP), for its report, ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... the first two episodes of WE TV’s “Mama June: From Not to Hot,” which ... of TV notable, “Mama” June Shannon, known to millions from the 2012 reality television ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the ... Sheppard Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Februar 2017 LG Innotek hat heute die ... Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... zwischen 200 und 280 nm und eignet sich damit für ... ihre DNA zerstört. Das Produkt von LG Innotek erzeugt ... ...
(Date:2/23/2017)... 23, 2017 Nevro Corp. (NYSE: NVRO), a global ... the treatment of chronic pain, today reported financial results for ... 2016 Accomplishment & Highlights: ... an increase of 228% as reported, over the prior year ... increase of 612% over the prior year ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
Breaking Medicine Technology: